Martin Egenti

Internal Medicine physician in Owosso, Michigan — also lists obesity medicine in the CMS registry.

Practice Details

Address
826 W King St
Owosso, MI 48867
Geocoded location: 43.0051, -84.1804
Taxonomy
Internal Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2008
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
May 2019

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Surgery
  • Internal Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Martin Egenti is an Internal Medicine physician in Owosso whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 25 Internal Medicine practices in Owosso carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • A discussion of GLP-1 options for diabetes and/or weight management.
  • A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Martin Egenti's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 899-723-5211.

GLP-1 access in Owosso, Michigan

Adult obesity rate
34.5%
#13 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$199/mo
Typical Michigan telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Michigan Medicaid, obesity indication

About 34.5% of Michigan adults have obesity (BMI 30+), ranking the state #13 of 50 (CDC BRFSS). Our directory currently lists 6 GLP-1-relevant clinics in Owosso. If a cash-pay route makes more sense, compounded semaglutide through Michigan telehealth averages about $199/mo — well below brand-name Wegovy or Zepbound.

Explore more Michigan options on the best Michigan GLP-1 providers page, browse every Owosso listing in the Owosso clinic directory, or read the Michigan Medicaid GLP-1 coverage & prior-authorization guide.

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Michigan addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Michigan telehealth partners:

Featured Partners · Owosso

Featured GLP-1 providers serving Owosso

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  2. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  5. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  6. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →

See more Owosso options on the Owosso clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Owosso obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Martin Egenti's specialty taxonomy but not the specific medications it prescribes or its current service menu. Martin Egenti is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 899-723-5211 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Martin Egenti's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Martin Egenti is located at 826 W King St, Owosso, MI 48867. The phone number listed in the registry is 899-723-5211. Its full record is public in the CMS National Provider registry under NPI 1871741694.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Martin Egenti is currently accepting new patients. Call the practice at 899-723-5211 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.